You are here
Global Biologics Drug Discovery Market Report 2016-2024
Global Biologics Drug Discovery Market Report
Global Biologics Drug Discovery Market
According to Goldstein Research, global biologics drug discovery market is expected to reach USD 140.9 billion by 2024 from an estimated market size of USD 56.6 billion in 2016, growing at a CAGR of 12.0% over the forecast period 2016-2024. The high presence of genetic disorders, diabetes, nervous system disorders and cardiovascular diseases and advancement in the field of genetics, structural biology and biotechnology tend to drive the growth of the market.
Global biologics drug discovery market segmentation has been done on the basis of technology, end user and geography. Geographically, the global biologics drug discovery industry is dominated by North America with a market share of 38.0% in 2016, owing to high investments in the healthcare and pharmaceutical industry.
Download Exclusive Sample Request @ https://www.goldsteinresearch.com/request-sample/global-biologics-drug-discovery-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024
Global Biologics Drug Discovery Market can be segmented as follows:
- DNA Microarrays
- Protein Microarrays
- High-throughput screening
- Mass Spectrometry
- Gel Electrophoresis
- Protein and Nucleic Acid Isolation
- Other technologies
By End User
- Outsourcing (Contract Research Organization)
- Insourcing (Within the Organization)
- North America Biologics Drug Discovery Market Analysis, 2016-2024
- Europe Biologics Drug Discovery Market Analysis, 2016-2024
- The Middle East And Africa Biologics Drug Discovery Market Analysis, 2016-2024
- Latin America Biologics Drug Discovery Market Analysis, 2016-2024
- Asia Pacific Biologics Drug Discovery Market Analysis, 2016-2024
- Rest Of The World Biologics Drug Discovery Market Analysis, 2016-2024
“Biologics Drug Discovery Industry Analysis” contains the detailed overview of the global biologics drug discovery market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by technology, end user and geography.
The Global Biologics Drug Discovery Market Report highlights the competitive analysis of major players and their company profiling discusses the business strategies analysis, revenue distribution by geography & business segments, financial analysis and investments by the company.
Key players of the global biologics drug discovery market discussed in the report are: Johnson and Johnson, Bayer AG, Sanofi, Novartis, AstraZeneca PLC, Pfizer Inc., Merck & Co. Inc., Boehringer Ingelheim Inc., Glaxosmithkline LLC, Eli Lily, Roche Holding AG., Infosys, Charles River Laboratories, Albany Molecular Research Inc., Boehringer Ingelheim GmBh, Covance, Jubilant Biosys, etc.
Further, Global Biologics Drug Discovery Market Report encompasses the analysis of market drivers, opportunities, trends, risk analysis, challenges, market attractiveness, Porter’s five force model, SWOT analysis and BPS analysis.
The market research report also includes the market share, market size, growth rate, and relevant statistics to provide market insights to the stakeholders in the market in order to formulate business strategies.
Browse Similar Reports: Biopolymers Industry
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts.
Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare market analysis reports helping various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.